The purpose of this study is to better understand how X-linked hypophosphatemia (XLH) affects the body and daily life. Phosphate levels are critical in managin…

X-linked Hypophosphatemia (XLH)

~Estimated

~$10 – $1,125

Novo Nordisk A/SNCT07607600

Phase 2

Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients

The primary goal is to determine if Dipyridamole can improve serum phosphate levels and reduce the need for phosphate supplementation.

HypophosphatemiaKidney Transplantation

~Estimated

~$10 – $6,250

Stanford UniversityNCT06824454

Phase 1

The Impact of Phosphate Metabolism on Healthy Aging

Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/nephrolithiasis), vascular (endothelial…

HypophosphatemiaRicketsHypercalciuria+2 more

~Estimated

~$10 – $6,250

Yale UniversityNCT03771105